Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Retinol binding protein 4 (RBP4) is a lipocalin that serves as the primary transport protein for retinol (vitamin A) in the bloodstream. Synthesized mainly in the liver and adipose tissue, it circulates bound to retinol and transthyretin (TTR). RBP4 delivers retinol to peripheral tissues via receptors like STRA6 and is implicated in glucose and lipid metabolism. Elevated levels are associated with insulin resistance and metabolic diseases.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Retinol binding protein 4 (RBP4).